Business Wire

NEXI-S.P.A.

9.5.2024 08:01:36 CEST | Business Wire | Press release

Share
Group Financial Results as of March 31st 2024 Approved, Continued Growth and EBITDA Margin Expansion, € 500 Million Share Buy-Back Program Launched

The Board of Directors of Nexi S.p.A. approved on May 8th the Group’s consolidated financial results as of March 31st 2024.

Key consolidated financial managerial results1

In 1Q24 the Group delivered revenues at € 781.6 million, +6.0% versus 1Q23, and EBITDA at € 361.7 million, +8.6% versus 1Q23. The EBITDA margin was at 46%, up by 112 basis points compared to 1Q23, also thanks to the accelerating efficiencies and cost synergies delivery on the back of Group integration.

Nexi Group’s operating businesses delivered the following results in 1Q24:

  • Merchant Solutions, representing approximately 56% of Group's total revenues, reported revenues of € 437.7 million, +6.8% Y/Y, with eCommerce growing double-digit driven by accelerated customer base growth and volume growth. In 1Q24, 4,514 million transactions were processed, +9.5% Y/Y, with value of processed transactions at € 192.5 billion, +5.0% Y/Y. In 1Q24 there has been a continued international schemes sales volume growth in all geographies, with DACH region growing double-digit Y/Y and Italy high single-digit. During the quarter, SMEs acquiring volumes continued to grow driven by customer base expansion, particularly in Italy and DACH region.

    Nexi firmly believes that convergence of digital payments and software for SME is a topic that will contribute to shape the industry in the next years. Therefore, Nexi continues to reinforce its position as the "partner of choice" in Europe for best-in-class local ISVs, with >500 ISVs partners in 8 markets and POS solutions already being sold by Nexi channels in the Nordics and Germany, to be extended over time to additional markets and verticals.
  • Issuing Solutions, representing approximately 33% of Group's total revenues, reported revenues of € 257.6 million in 1Q24, +5.2% Y/Y. The growth was mainly supported by the performance in Italy, benefitting from the acceleration of international debit. In 1Q24, 4,737 million transactions were processed, +8.2% Y/Y, with value of processed transactions at € 207.9 billion, +4.6% Y/Y.
  • Digital Banking Solutions, representing approximately 11% of Group's total revenues, reported revenues of € 86.3 million, +4.3% Y/Y, sustained by volume growth and positive impact from new initiatives. Specifically, during the first quarter, Nexi launched a new pan-European antifraud solution for EBA Clearing’s SEPA credit transfers and Instant payments.

In 1Q24, Total Costs were at € 419.9 million, with a growth of 3.8% Y/Y mainly thanks to the operating leverage and to synergies and efficiencies, as well as some phasing effects, despite volume and business growth and inflationary pressure.

As of March 31st 2024, the Net Financial Debt was down to € 5,035 million, while the Net Financial Debt / EBITDA ratio decreased at 2.8x. The weighted average debt maturity is ~2.8 years with an average pre-tax cash cost of debt, stable versus FY23, of ~2.86%. With reference to the ~€ 1.3 billion of 2024-2025 debt maturities, Nexi confirms its plan to fully pay down them with the existing cash; in particular, ~€ 220 million have been already reimbursed in April 2024.

2024 Guidance confirmed

For 2024, considering the persistent complex macro-outlook, Nexi confirms the following targets:

  • Net revenues: Mid-single digit Y/Y growth;
  • EBITDA: Mid-to-high single digit Y/Y growth, with margin expansion of 100 bps+;
  • Excess cash generation: More than € 700 million;
  • Net leverage: decreasing to below 2.9x including announced M&A and share buy-back effects, (~2.6x on organic basis).

Significant subsequent events

  • Nexi announces the start of a share buy-back program up to 500 €M to be completed by October 31st, 2025 and already approved by the Shareholders' meeting on April 30th, 2024.

    The substantial existing cash balances and the strong current and expected cash generation growth allow to start returning capital to Shareholders in 2024, while still continuing to support the planned debt reduction and the limited M&A opportunities in the future. Nexi’s management and the Board believe that the current share price does not reflect the full value of its business and outlook and that a share buy-back offers the most effective value creating opportunity for the shareholders to deploy the excess cash. In the longer term, Nexi plans to continue to allocate a material portion of excess capital to shareholders either through further share buy-back programs or dividends depending on overall market conditions.
  • On April 8th, 2024, the bonds issued by Nassa TopCo AS for a nominal amount of about € 219.6 million, plus the accrued interest, were redeemed at maturity using the already available cash.
  • Following the resignation of Mr. Bo Nilsson from the Board of Directors occurred on April 30th, 2024, the Board of Directors of the Company during yesterday’s meeting, appointed by co-optation Mr. Luca Velussi as a non-executive and non independent Director, after the favorable opinion of the Board of Statutory Auditors. His curriculum vitae is available in the governance section of the company website www.nexigroup.com. Mr. Luca Velussi will remain in post until the next Shareholders' Meeting and, as of today, does not own any Nexi share.

Pursuant to paragraph 2 of article 154 bis of the Consolidated Finance Act, the undersigned, Enrico Marchini, in his capacity as the manager in charge of preparing Nexi’s financial reports, declares that the accounting information contained in this press release corresponds to the accounting documents, books and records of Nexi S.p.A..

Disclaimer: This is the English translation of the original Italian press release “Approvati i risultati finanziari di Gruppo al 31 marzo 2024”. In any case of discrepancy between the English and the Italian versions, the original Italian document is to be given priority of interpretation for legal purposes.

Nexi

Nexi is Europe's PayTech company operating in high-growth, attractive European markets and technologically advanced countries. Listed on Euronext Milan, Nexi has the scale, geographic reach and abilities to drive the transition to a cashless Europe. With its portfolio of innovative products, e-commerce expertise and industry-specific solutions, Nexi provides flexible support for the digital economy and the entire payment ecosystem globally, across a broad range of different payment channels and methods. Nexi’s technological platform and the best-in-class professional skills in the sector enable the company to operate at its best in three market segments: Merchant Solutions, Issuing Solutions and Digital Banking Solutions. Nexi constantly invests in technology and innovation, focusing on two fundamental principles: meeting, together with its partner banks, customer needs and creating new business opportunities for them. Nexi is committed to supporting people and businesses of all sizes, transforming the way people pay and businesses accept payments. It offers companies the most innovative and reliable solutions to better serve their customers and expand. By simplifying payments and enabling people and businesses to build closer relationships and grow together, Nexi promotes progress to benefit everyone. www.nexi.it/en www.nexigroup.com

1 2023 and 2024 pro-forma normalised managerial data at constant scope and FX (average 2024 budget FX).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240508329060/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release

SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release

Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a

Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release

Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release

GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc

Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release

Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye